Clinical Trial Update: Microfluidic Device to Diagnose Leptomeningeal Metastasis in Breast Cancer

View source ↗

Summary

The ClinicalTrials.gov record indicates the study evaluating a microfluidic diagnostic device for leptomeningeal metastasis in breast cancer has completed enrol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Leptomeningeal Metastasis

Snippet

Sponsor: Columbia University | Conditions: Breast Cancer, Leptomeningeal Metastasis | Status: COMPLETED | Results posted: 2024-06-06